Literature DB >> 24190025

Chronic and acute intranasal oxytocin produce divergent social effects in mice.

Huiping Huang1, Caterina Michetti2, Marta Busnelli3, Francesca Managò1, Sara Sannino1, Diego Scheggia1, Luca Giancardo4, Diego Sona4, Vittorio Murino4, Bice Chini5, Maria Luisa Scattoni6, Francesco Papaleo7.   

Abstract

Intranasal administration of oxytocin (OXT) might be a promising new adjunctive therapy for mental disorders characterized by social behavioral alterations such as autism and schizophrenia. Despite promising initial studies in humans, it is not yet clear the specificity of the behavioral effects induced by chronic intranasal OXT and if chronic intranasal OXT could have different effects compared with single administration. This is critical for the aforementioned chronic mental disorders that might potentially involve life-long treatments. As a first step to address these issues, here we report that chronic intranasal OXT treatment in wild-type C57BL/6J adult mice produced a selective reduction of social behaviors concomitant to a reduction of the OXT receptors throughout the brain. Conversely, acute intranasal OXT treatment produced partial increases in social behaviors towards opposite-sex novel-stimulus female mice, while on the other hand, it decreased social exploration of same-sex novel stimulus male mice, without affecting social behavior towards familiar stimulus male mice. Finally, prolonged exposure to intranasal OXT treatments did not alter, in wild-type animals, parameters of general health such as body weight, locomotor activity, olfactory and auditory functions, nor parameters of memory and sensorimotor gating abilities. These results indicate that a prolonged over-stimulation of a 'healthy' oxytocinergic brain system, with no inherent deficits in social interaction and normal endogenous levels of OXT, results in specific detrimental effects in social behaviors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24190025      PMCID: PMC3957104          DOI: 10.1038/npp.2013.310

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  57 in total

Review 1.  Autism and oxytocin: new developments in translational approaches to therapeutics.

Authors:  Joshua J Green; Eric Hollander
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Oxytocin improves male copulatory performance in rats.

Authors:  R Arletti; C Bazzani; M Castelli; A Bertolini
Journal:  Horm Behav       Date:  1985-03       Impact factor: 3.587

Review 3.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.

Authors:  Andreas Meyer-Lindenberg; Gregor Domes; Peter Kirsch; Markus Heinrichs
Journal:  Nat Rev Neurosci       Date:  2011-08-19       Impact factor: 34.870

4.  Selective amnesic effects of oxytocin on human memory.

Authors:  Markus Heinrichs; Gunther Meinlschmidt; Werner Wippich; Ulrike Ehlert; Dirk H Hellhammer
Journal:  Physiol Behav       Date:  2004-10-30

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

6.  Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides.

Authors:  P Popik; J Vetulani; J M Van Ree
Journal:  Eur J Pharmacol       Date:  1996-07-18       Impact factor: 4.432

7.  Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.

Authors:  Masaya Tachibana; Kuriko Kagitani-Shimono; Ikuko Mohri; Tomoka Yamamoto; Wakako Sanefuji; Ayumi Nakamura; Masako Oishi; Tadashi Kimura; Tatsushi Onaka; Keiichi Ozono; Masako Taniike
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

8.  Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice.

Authors:  Francesco Papaleo; Jacqueline N Crawley; Jian Song; Barbara K Lipska; Jim Pickel; Daniel R Weinberger; Jingshan Chen
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

9.  Sex, receptors, and attachment: a review of individual factors influencing response to oxytocin.

Authors:  Kai S Macdonald
Journal:  Front Neurosci       Date:  2013-01-10       Impact factor: 4.677

10.  Automatic visual tracking and social behaviour analysis with multiple mice.

Authors:  Luca Giancardo; Diego Sona; Huiping Huang; Sara Sannino; Francesca Managò; Diego Scheggia; Francesco Papaleo; Vittorio Murino
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more
  64 in total

1.  Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety.

Authors:  Erwin H van den Burg; Benjamin Jurek; Inga D Neumann; Julia Winter; Magdalena Meyer; Ilona Berger; Melanie Royer; Marta Bianchi; Kerstin Kuffner; Sebastian Peters; Simone Stang; Dominik Langgartner; Finn Hartmann; Anna K Schmidtner; Stefan O Reber; Oliver J Bosch; Anna Bludau; David A Slattery
Journal:  Mol Psychiatry       Date:  2021-05-25       Impact factor: 15.992

2.  Genetic modulation of oxytocin's effects in social functioning.

Authors:  Huiping Huang; Francesco Papaleo
Journal:  Ann Transl Med       Date:  2015-12

3.  Do marmosets care to share? Oxytocin treatment reduces prosocial behavior toward strangers.

Authors:  Aaryn C Mustoe; Jon Cavanaugh; April M Harnisch; Breanna E Thompson; Jeffrey A French
Journal:  Horm Behav       Date:  2015-04-28       Impact factor: 3.587

Review 4.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

Review 5.  Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.

Authors:  Wadih Jean Naja; Michaelangelo Pietro Aoun
Journal:  Curr Psychiatry Rep       Date:  2017-08-15       Impact factor: 5.285

6.  A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.

Authors:  L Fredrik Jarskog; Cort A Pedersen; Jacqueline L Johnson; Robert M Hamer; Shane W Rau; Tonya Elliott; David L Penn
Journal:  Schizophr Res       Date:  2017-01-13       Impact factor: 4.939

7.  Inhaled oxytocin increases positive social behaviors in newborn macaques.

Authors:  Elizabeth A Simpson; Valentina Sclafani; Annika Paukner; Amanda F Hamel; Melinda A Novak; Jerrold S Meyer; Stephen J Suomi; Pier Francesco Ferrari
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.

Authors:  Francesca Managò; Maddalena Mereu; Surjeet Mastwal; Rosa Mastrogiacomo; Diego Scheggia; Marco Emanuele; Maria A De Luca; Daniel R Weinberger; Kuan Hong Wang; Francesco Papaleo
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

9.  Effects of chronic oxytocin on attention to dynamic facial expressions in infant macaques.

Authors:  Lisa A Parr; Jenna M Brooks; Trina Jonesteller; Shannon Moss; James O Jordano; Thomas R Heitz
Journal:  Psychoneuroendocrinology       Date:  2016-08-31       Impact factor: 4.905

10.  Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum.

Authors:  Iulia Zoicas; David A Slattery; Inga D Neumann
Journal:  Neuropsychopharmacology       Date:  2014-06-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.